|
New Page 1
How Does It Work?:
Esberitox
is a unique blend of wild indigo root, coneflower root, and white cedar leaf
that has been widely used in Europe for decades. This powerful combination of
herbs fortifies the defense mechanism of body, supports to strengthen the body's
natural defense mechanisms.
Research has shown that
the Esberitox combination provides a broader range of activity than any
individual component alone. This additive effect is produced via the actions and
interactions of the concentrated botanical extracts. Although the activity of
the individual components overlap in some way, each herb is unique in how it
enhances immune function.
The following table
summarizes the key benefits of each ingredient:
|
Ingredient |
Benefits |
|
Echinacea purpurea and pallida |
·
Increase interferon
production†
·
Stimulates B-cell and
antibody production†
·
Increases interleukin-1
production†
·
Increases production of
tumor necrosis factor† |
|
Wild
indigo (Baptisia tinctoria |
·
Increases interferon
production†
·
Stimulates B-cell and
antibody production†
·
Increases interleukin-1
production† |
|
Thuja occidentalis
(white cedar leaf) |
·
Enhances T-4 Enhanceer
cells and increases interleukin-2 production† |
|
Esberitox |
·
Increases chemotaxis of
white blood cells†
·
Increases phagocytosis
rate and killing capacity of neutrophils†
·
Activates macrophages†
·
Increases phagocytosis of
macrophages† |
Clinical Research
Findings
The safe and efficacious use of Esberitox in both children and adults has
been documented in over thirty clinical and scientific studies. Unlike
Echinacea, which has generated both negative and positive results, studies on
the Esberitox combination have yielded only positive findings.
Defense mechanism of
body Support
Several studies have examined the ability of Esberitox to quickly
and effectively enhance Defense mechanism of body function. The powerful
combination promotes the body's resistive functions by stimulating the
production and activity of critical immune cells.
One randomized,
double-blind, placebo controlled, multi-center study involving 263 adults, found
that improvement was noticeable after only two days of supplementation - three
days earlier than the placebo group. Similar benefits have been noted in
children, where safety and tolerability have been established for those as young
as two years of age.
Esberitox
is especially beneficial when extra defense mechanism of body support is
desired.† Clinical research has demonstrated that supplementation increased the
rate of phagocytosis by 7.4%, whereas the rate in the placebo group decreased
3.2%. Phagocytosis is a process through which immune cells rid the body of waste
and foreign bodies. Esberitox has also been shown to double the level of
killer cell activity and the lymphocyte count in individuals in need of immune
support.* These findings provide strong evidence of Esberitox's ability to
stimulate the defense mechanism of body.
|
